LUMOS PHARMA, INC. (LUMO) Operating Income (Loss) USD 2010 - 2024

Historical data

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Lumos Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2024.
Lumos Pharma, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$10.9 M, a 35.2% decline year-over-year.
Lumos Pharma, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$39.4 M, a 21.9% decline year-over-year.
Lumos Pharma, Inc. annual Operating Income (Loss) for 2023 was -$36.6 M, a 14.3% decline from 2022.
Lumos Pharma, Inc. annual Operating Income (Loss) for 2022 was -$32 M, a 2.21% decline from 2021.
Lumos Pharma, Inc. annual Operating Income (Loss) for 2021 was -$31.3 M, a 19.2% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2024	-$39.4 M	-$10.9 M	-$2.83 M	-35.2%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	-$36.6 M	-$10 M	-$1.17 M	-13.2%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-07
Q3 2023	-$35.4 M	-$8.93 M	-$1.38 M	-18.3%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-07
Q2 2023	-$34.1 M	-$9.64 M	-$1.72 M	-21.7%	Apr 1, 2023	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	-$32.3 M	-$8.04 M	-$304 K	-3.93%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	-$32 M	-$8.84 M	-$2.27 M	-34.5%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-07
Q3 2022	-$29.8 M	-$7.55 M	-$53 K	-0.71%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-07
Q2 2022	-$29.7 M	-$7.92 M	+$740 K	+8.54%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	-$30.5 M	-$7.73 M	+$886 K	+10.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-05
Q4 2021	-$31.3 M	-$6.57 M	+$485 K	+6.88%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-07
Q3 2021	-$31.8 M	-$7.5 M	-$340 K	-4.75%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$31.5 M	-$8.66 M	-$1.79 M	-26%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-10
Q1 2021	-$29.7 M	-$8.62 M	-$3.4 M	-65.2%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-11
Q4 2020	-$26.3 M	-$7.05 M	+$1.64 M	+18.8%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-11
Q3 2020	-$27.9 M	-$7.16 M	-$4.46 M	-165%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-05
Q2 2020	-$23.5 M	-$6.88 M	-$4.28 M	-165%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-06
Q1 2020	-$19.2 M	-$5.22 M	-$3.08 M	-144%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	-$16.1 M	-$8.69 M	+$2.26 M	+20.6%	Oct 1, 2019	Dec 31, 2019	10-K	2020-03-03
Q3 2019	-$18.4 M	-$2.7 M	+$12.3 M	+82.1%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-12
Q2 2019	-$30.7 M	-$2.6 M	+$15.2 M	+85.4%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-14
Q1 2019	-$45.9 M	-$2.14 M	+$16.6 M	+88.6%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-06-02
Q4 2018	-$62.4 M	-$10.9 M	+$3.11 M	+22.1%	Oct 1, 2018	Dec 31, 2018	10-K	2020-03-03
Q3 2018	-$65.5 M	-$15 M	+$5.87 M	+28.1%	Jul 1, 2018	Sep 30, 2018	10-K	2020-03-03
Q2 2018	-$71.4 M	-$17.7 M	-$1.02 M	-6.1%	Apr 1, 2018	Jun 30, 2018	10-K	2020-03-03
Q1 2018	-$70.4 M	-$18.7 M	+$2.49 M	+11.8%	Jan 1, 2018	Mar 31, 2018	10-K	2020-03-03
Q4 2017	-$72.9 M	-$14.1 M	-$81 K	-0.58%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-05
Q3 2017	-$72.8 M	-$20.9 M	-$4.22 M	-25.3%	Jul 1, 2017	Sep 30, 2017	10-K	2019-03-05
Q2 2017	-$68.6 M	-$16.7 M	+$17.8 M	+51.6%	Apr 1, 2017	Jun 30, 2017	10-K	2019-03-05
Q1 2017	-$86.4 M	-$21.2 M	+$4.2 M	+16.5%	Jan 1, 2017	Mar 31, 2017	10-K	2019-03-05
Q4 2016	-$90.6 M	-$14 M	+$855 K	+5.77%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-05
Q3 2016	-$91.4 M	-$16.7 M	-$1 M	-6.4%	Jul 1, 2016	Sep 30, 2016	10-K	2018-03-05
Q2 2016	-$90.4 M	-$34.5 M	-$18.6 M	-117%	Apr 1, 2016	Jun 30, 2016	10-K	2018-03-05
Q1 2016	-$71.8 M	-$25.4 M	-$38.2 M	-298%	Jan 1, 2016	Mar 31, 2016	10-K	2018-03-05
Q4 2015	-$33.6 M	-$14.8 M	-$164 M	-110%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-06
Q3 2015	$130 M	-$15.7 M	-$2.66 M	-20.4%	Jul 1, 2015	Sep 30, 2015	10-K	2017-03-06
Q2 2015	$133 M	-$15.9 M	-$6.82 M	-74.7%	Apr 1, 2015	Jun 30, 2015	10-K	2017-03-06
Q1 2015	$140 M	$12.8 M	+$22.2 M		Jan 1, 2015	Mar 31, 2015	10-K	2017-03-06
Q4 2014	$118 M	$149 M	+$157 M		Oct 1, 2014	Dec 31, 2014	10-K	2016-02-29
Q3 2014	-$39.4 M	-$13 M	-$4.91 M	-60.5%	Jul 1, 2014	Sep 30, 2014	10-K	2016-02-29
Q2 2014	-$34.5 M	-$9.13 M	-$2.06 M	-29.1%	Apr 1, 2014	Jun 30, 2014	10-K	2016-02-29
Q1 2014	-$32.4 M	-$9.3 M	-$1.26 M	-15.7%	Jan 1, 2014	Mar 31, 2014	10-K	2016-02-29
Q4 2013	-$31.1 M	-$7.91 M	-$1.62 M	-25.7%	Oct 1, 2013	Dec 31, 2013	10-K	2015-03-16
Q3 2013	-$29.5 M	-$8.12 M	-$2.27 M	-38.8%	Jul 1, 2013	Sep 30, 2013	10-K	2015-03-16
Q2 2013	-$27.3 M	-$7.07 M	-$768 K	-12.2%	Apr 1, 2013	Jun 30, 2013	10-K	2015-03-16
Q1 2013	-$26.5 M	-$8.04 M	-$3.23 M	-67%	Jan 1, 2013	Mar 31, 2013	10-K	2015-03-16
Q4 2012	-$23.3 M	-$6.29 M	-$489 K	-8.43%	Oct 1, 2012	Dec 31, 2012	10-K	2014-03-12
Q3 2012	-$22.8 M	-$5.85 M	-$1.88 M	-47.2%	Jul 1, 2012	Sep 30, 2012	10-K	2014-03-12
Q2 2012	-$20.9 M	-$6.3 M	-$1.91 M	-43.4%	Apr 1, 2012	Jun 30, 2012	10-K	2014-03-12
Q1 2012	-$19 M	-$4.82 M	-$925 K	-23.8%	Jan 1, 2012	Mar 31, 2012	10-K	2014-03-12
Q4 2011	-$18.1 M	-$5.8 M			Oct 1, 2011	Dec 31, 2011	10-K	2013-03-15
Q3 2011		-$3.97 M	+$1.14 M	+22.3%	Jul 1, 2011	Sep 30, 2011	10-K	2013-03-15
Q2 2011		-$4.39 M			Apr 1, 2011	Jun 30, 2011	10-K	2013-03-15
Q1 2011		-$3.89 M			Jan 1, 2011	Mar 31, 2011	10-K	2013-03-15
Q3 2010		-$5.11 M			Jul 1, 2010	Sep 30, 2010	10-Q/A	2012-01-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.